AU6376194A - Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer - Google Patents

Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer

Info

Publication number
AU6376194A
AU6376194A AU63761/94A AU6376194A AU6376194A AU 6376194 A AU6376194 A AU 6376194A AU 63761/94 A AU63761/94 A AU 63761/94A AU 6376194 A AU6376194 A AU 6376194A AU 6376194 A AU6376194 A AU 6376194A
Authority
AU
Australia
Prior art keywords
cell
diagnostic
cancer
human
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63761/94A
Inventor
Jozephus Carolus Martha Raus
Jingwu Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DR L WILLEMS-INSTITUUT
Original Assignee
L WILLEMS INSTITUUT DR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L WILLEMS INSTITUUT DR filed Critical L WILLEMS INSTITUUT DR
Publication of AU6376194A publication Critical patent/AU6376194A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464839—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU63761/94A 1993-05-14 1994-03-10 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer Abandoned AU6376194A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP93870081 1993-05-14
EP93870081 1993-05-14
PCT/EP1994/000742 WO1994026876A1 (en) 1993-05-14 1994-03-10 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer

Publications (1)

Publication Number Publication Date
AU6376194A true AU6376194A (en) 1994-12-12

Family

ID=8215343

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63761/94A Abandoned AU6376194A (en) 1993-05-14 1994-03-10 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer

Country Status (6)

Country Link
EP (1) EP0698087A1 (en)
JP (1) JPH09500261A (en)
AU (1) AU6376194A (en)
CA (1) CA2162853A1 (en)
IL (1) IL108926A0 (en)
WO (1) WO1994026876A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1218506A (en) * 1996-03-13 1999-06-02 盐野义制药株式会社 Human T cell clone specific for rheumatoid arthrilis
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
CN100567987C (en) 2002-08-08 2009-12-09 贝勒医学院 T cell vaccine and preparation method thereof
US9206394B2 (en) 2010-02-03 2015-12-08 The University Of Tokyo Method for reconstructing immune function using pluripotent stem cells
JPWO2011096482A1 (en) * 2010-02-03 2013-06-13 国立大学法人 東京大学 Immune function reconstruction using pluripotent stem cells
US9107878B2 (en) * 2010-04-06 2015-08-18 Exocyte Therapeutics Pte, Ltd Methods of treating cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8405555D0 (en) * 1984-03-02 1984-04-04 Rees A D M Macrophage activating factors
EP0203403B1 (en) * 1985-05-01 1992-10-28 Asahi Kasei Kogyo Kabushiki Kaisha A cloned t cell capable of recognizing tumors and a t cell antigen receptor
JPH0297378A (en) * 1988-10-03 1990-04-09 Asahi Chem Ind Co Ltd Cloned human killer t cell strain
WO1990011294A1 (en) * 1989-03-21 1990-10-04 The Immune Response Corporation Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
CA2110055C (en) * 1991-05-31 2002-08-20 Arthur A. Vandenbark T cell receptor peptides as therapeutics for immune-related disease

Also Published As

Publication number Publication date
IL108926A0 (en) 1994-06-24
CA2162853A1 (en) 1994-11-24
EP0698087A1 (en) 1996-02-28
WO1994026876A1 (en) 1994-11-24
JPH09500261A (en) 1997-01-14

Similar Documents

Publication Publication Date Title
AU7678096A (en) Therapeutic medical garments for scars and process
AU623598B2 (en) Medical instrument and production thereof
AU2382588A (en) Medical instrument and production thereof
AU6391394A (en) Medical devices and methods of manufacture
AU6129294A (en) Medical examination garment
AU7250294A (en) Treatment of multidrug resistant diseases
AU7397994A (en) Improved patient/nurse call system
AU2614888A (en) Soluble human cd4 fragments and uses therefor
AU5457494A (en) Methods and procedures for preparing red blood fractions
AU1555095A (en) Disposable filters and manufacturing process
AU3892593A (en) Composition for therapeutic or diagnostic use, process for its preparation and its use
AU3171793A (en) Process for producing copolymer latex and use thereof
AU6376194A (en) Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer
AU4840696A (en) Medical and surgical adhesive composition and process for its preparation
AU6467696A (en) Mocarhagin, a cobra venom protease, and therapeutic uses thereof
ZA9410254B (en) Disposable filters and manufacture process
HUP9802834A3 (en) Preparations for the treatment of t cell mediated autoimmune diseases
AU2403988A (en) Processed red blood cells and process for producing the same
AU4511089A (en) Human leukocyte elastase inhibitors and methods of producing and using same
AU7316196A (en) Diagnosis of susceptibility to cancer and treatment thereof
AU4178189A (en) Therapeutic agent for aids and process for preparing it
AU6525096A (en) Modified human chorionic (beta-hcg) proteins and their medical use
AU7737991A (en) Medical uses of m-csf
AU6491890A (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
AU5703494A (en) High performance composite material especially for dental and medical use and process for its production